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High liver iron content is a risk factor for developing hepatocellular carcinoma (HCC). However, HCC cells are always iron-poor. Therefore,
an association between hepatocyte iron storage capacity and differentiation is suggested. To characterize biological processes involved in iron
loading capacity, we used a cDNA microarray to study the differentiation of the human HepaRG cell line, from undifferentiated proliferative cells
to hepatocyte differentiated cells. We were able to identify genes modulated along HepaRG differentiation, leading us to propose new genes not
previously associated with HCC. Moreover, using Gene Ontology annotations, we demonstrated that HepaRG hepatocyte iron loading capacity
occurred both with the repression of genes involved in cell motility, signal transduction, and biosynthesis and with the appearance of genes linked
to lipid metabolism and immune response. These results provide new insights in the understanding of the relationship between iron and hepatocyte
differentiation during iron-related hepatic diseases.
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Hepatocellular carcinomaIntroduction
Hepatocytes play a key role in ironmetabolism through: (i) the
production of serum proteins including transferrin [1], cerulo-
plasmin [1], haptoglobin [2], hemopexin [3], and hepcidin [4];
(ii) their capacity to take up iron present in excess in plasma,
especially the non-transferrin-bound iron species [5,6]; and (iii)
the ability of hepatic cells to store excessive iron inside ferritin
molecules [7]. In humans, hepatic iron overload diseases may
occur, especially during genetic hemochromatosis linked to the
C282Y mutation of the HFE gene ([8], review in [9]), and then0888-7543/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.ygeno.2005.08.016
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E-mail address: olivier.loreal@rennes.inserm.fr (O. Lore´al).lead to the development of cirrhosis and hepatocellular carcino-
ma [10].Moreover, during non-iron-related chronic liver diseases
such as viral hepatitis or alcoholic diseases, patients developing
hepatocellular carcinoma frequently exhibit an increase in
hepatic iron concentration in the nontumoral area of the liver
compared to patients without hepatocellular carcinoma, whereas
hepatocellular carcinoma cells, which are proliferating and
dedifferentiated, are free of iron deposits [11,12].
All these data suggest that iron may play a role in hepatic
carcinogenesis and, reciprocally, that iron metabolism in
hepatocytes is strongly modulated by the hepatocyte prolifer-
ation and/or differentiation status.
Adult hepatocytes are involved in many biological process-
es including the detoxification of xenobiotics, secretion of06) 93 – 103
www.el
Table 1
Repertoire of the human liver dedicated microarray
Gene ontology terms:
biological processes
% of annotated
genes
Total array gene
number
Metabolism 66.2 221
Cellular physiological process 35.6 119
Response to stimulus 23.4 78
Organismal physiological process 20.1 67
Cell communication 17.7 59
Regulation of physiological process 8.4 28
Regulation of cellular process 8.4 28
Death 6.6 22
Morphogenesis 6.3 21
Coagulation 3.0 10
Homeostasis 2.7 9
Regulation of enzyme activity 2.4 8
? Others X 7.2 24
Genes annotated at level 3 334
Unclassified 204
Total gene number 584
Level 3 Gene Ontology biological processes represented on the cDNA
microarray. Some genes are annotated by several terms, and some others are
not annotated. ‘‘Others’’ gathers biological processes representing each less
than 2% of total array genes.
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secretion. In addition, they are also the main target for viruses
having hepatic tropism. The HepaRG cell line, previously
obtained from a hepatocellular carcinoma complicating chronic
hepatitis C, revealed original biological characteristics. Indeed,
this cell line evolves from bipotent progenitor cells toward both
hepatocyte-like and primitive biliary epithelial cells [13,14]. In
contrast with other hepatocyte-derived human cell lines, a
feature of this cell line is its capacity to evolve from a
proliferative undifferentiated stage to a very high level of
hepatocyte differentiation reflected by the expression of
xenobiotic detoxification pathways. This kinetics parallels
liver development. Finally, HepaRG is thus far the only cell
line able to support hepatitis B virus infection [13] similarly to
primary human hepatocytes [15]. Taken together, these results
suggest that the HepaRG cell line is a valuable model
mimicking adult hepatocytes. Thus, the HepaRG cell line can
be used to characterize the relationship between iron and
hepatocytes.
Therefore, our aim was to analyze, using a transcriptomic
approach through a liver-dedicated cDNA microarray, the
relationship between iron storage capacity and hepatocyte
differentiation status in the HepaRG cell line. Our data enabled
us to identify the differentiation steps that are associated with
iron storage capacity and to highlight biological processes
modulated at these steps.
Results
Human liver microarray
The four cDNAs libraries obtained from human hepatocel-
lular carcinoma and HepaRG cell line were used to build the
human liver dedicated microarray. The median cDNA insert
size of the 2436 selected clones was 489 bp. These clones, as
well as a set of 36 PCR-amplified genes involved in iron
metabolism, were representative of 584 distinct genes. Both
human liver libraries and HepaRG libraries contributed 58 and
30%, respectively, of the genes, whereas 12% of the genes
were found in both libraries. The involvement of these genes in
different biological processes was evaluated at level 3 in Gene
Ontology (GO) and the results are presented in Table 1. A total
of 12 biological processes were represented by more than
8 genes. The most represented biological process was
‘‘metabolism’’ with cDNAs representing genes such as albumin
(ALB) or the cytochrome p450 family. This cDNA microarray
gave us the opportunity to analyze the relationship between
iron storage capacity and hepatocyte differentiation process.
HepaRG differentiation kinetics
Based on both phenotype and morphologic criteria from
phase-contrast microscopy observations [13,14] (Fig. 1A), we
distinguished four distinct steps in the HepaRG differentiation
process. At the first stage of differentiation, HepaRG cells
presented a homogeneous epithelial phenotype [13] associated
with intense cell proliferation. During the second stage, whenreaching confluence, the cell proliferation rate decreased,
despite the absence of any significant morphological changes.
Morphologic and phenotypic changes appeared approximately
10 to 15 days postplating when cells were superconfluent,
corresponding to the third stage of differentiation. Two cell
populations appeared with polarized hepatocyte-like cell
colonies with biliary canaliculi and biliary-like epithelial cells
[14]. At the fourth stage, the addition of dimethylsulfoxide
reinforced the hepatocyte morphology, including the presence
of biliary canaliculi within hepatocyte-like cell colonies [13].
Identification of modulated genes
A lot of genes—from 140 to 221 genes depending on the
considered step—were significantly modulated along the
HepaRG differentiation process. The exhaustive list of signif-
icantly modulated genes is available at http://u522.rennes.
inserm.fr/donnees/troadec.htm. We identified two clusters of
co-regulated genes, those that were constantly significantly up-
regulated and those that were down-regulated along HepaRG
differentiation kinetics. These clusters are presented in Table 2.
In the first group of down-regulated genes, we noted some
genes implicated in cell growth, macromolecule metabolism,
and biosynthesis, including elongation factors (e.g., EEF1A1)
and ribosomal proteins (e.g., RPL10 and RPL2). These genes,
including three that were not annotated in GO regarding a
biological process, had a similar expression profile. They are
potentially involved in a common functional network.
In order to validate the results of our hybridizations, we tested
12 gene expression profiles at each differentiation stage by
quantitative RT-PCR (Fig. 2). All of the up-regulated genes
(ADH1B, TF, HP, and CP) and RNF10 were validated by
quantitative RT-PCR. For the down-regulated genes identified
Fig. 1. HepaRG differentiation kinetics and iron storage. Four distinct grades of HepaRG differentiation are followed: proliferation, confluence, superconfluence, and
differentiation. (A) Phase-contrast microscopy. Hepatocyte-like cells (hep) become visible during superconfluence and formed colonies with biliary canaliculi (bc).
Iron loading capacity is expressed by Perls_ staining after addition of 20 AM iron–citrate (B) or 200 AM citrate for the control (C). The presence of iron excess is
visible as blue granules within hepatocytes (i). Original magnification, 100.
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NFE2L2, and DDEF1), only NFE2L2 and DDEF1 were
markedly down-regulated in quantitative RT-PCR, whereas
SLC11A2, CYBRD1, and TFRC had weaker modulation profiles
than those observed with microarray technology. We could not
make any conclusions regarding SELENBP1 and AFP.
Identification of modulated biological processes
Using GoMiner software, we identified 28 Gene Ontology
biological processes corresponding to 11 GO classes at level 4
significantly enriched along HepaRG differentiation (Table 3).
They corresponded to the following processes: cell growth and/
or maintenance, regulation of body fluids, response to stimulus,
immune response, cell motility, signal transduction, biosynthe-
sis, energy pathways, and metabolism of macromolecules,
lipids, and organic acids. The biological process ‘‘cell growth
and/or maintenance’’ was significantly modulated only when
cells passed from proliferation to confluence. Then, genes
involved in the regulation of body fluids, response to stimulus,
and immune response were up-regulated from the proliferation
to the superconfluence state. In contrast, when cells reached
superconfluence, genes involved in cell motility and signal
transduction were repressed. Finally, during final differentiation,
the biosynthesis and the energy pathways were down-regulated,
whereas genes associated with the metabolism of lipids and
organic acids were significantly overexpressed.
Gene expression profiles in HepaRG and hepatocellular
carcinoma
To extend results obtained using the HepaRG cell line and
cDNA microarray, we analyzed in human samples theexpression of some genes implicated in cell motility (RAC1,
MSN, TPM3, FN1) or in lipid metabolism (FABP1, CYP4F2,
UGT2B7, and PLCG2) in the HepaRG cell line. These genes
were respectively repressed and up-regulated along HepaRG
differentiation kinetics (Table 3). By testing the gene expres-
sion in nontumoral livers versus paired hepatocellular carcino-
ma, we found that RAC1, MSN, and TPM3 were significantly
down-regulated (Fig. 3).
Superconfluence is the critical step for hepatocyte iron
accumulation
To reveal the iron storage capacity of the HepaRG line, we
exposed the culture to iron–citrate, mimicking the non-
transferrin-bound iron found in the plasma of iron-overloaded
patients [16,17]. We used Perls_ staining to reveal iron excess
because this histological method is well correlated with direct
chemical measurement [18] and also allowed us to visualize
the cell population involved in iron storage (Figs. 1B and
1C). Iron accumulation was visualized neither at proliferation
nor at confluent stages, when the culture remained mono-
morphic. However, at the superconfluence stage, when
hepatocyte-like colonies appeared, iron deposits were found
within hepatocyte cytoplasm and were present within these
cells until final differentiation. In contrast, biliary-like
epithelial cells did not exhibit significant iron storage at any
stage.
Some biological processes were not associated with iron
loading capacity
Under basal culture conditions, we found a strong modu-
lation of biological processes, such as cell growth and/or
Table 2
List of genes which are constantly significantly down-regulated or up-regulated along HepaRG differentiation kinetics
Level 4 Gene Ontology biological processes corresponding to each gene are represented in grey. Some genes are annotated by several terms, and some others are not
annotated.
M.-B. Troadec et al. / Genomics 87 (2006) 93–10396maintenance, hemostasis, response to stimulus, and immune
response (Table 3), when cells passed from proliferation to
confluence states. However, these phenotypic modifications
were not sufficient to confer iron storage capacity when cells
were exposed to iron (Figs. 1B and 1C).
Some biological processes were associated with iron loading
capacity
Under basal culture conditions, from confluence to super-
confluence, genes involved in hemostasis, response to stimu-
lus, and immune response were still up-regulated, whereas
genes involved in cell motility and the protein kinase cascade
(signal transduction) were underexpressed (Table 3). At this
time, hepatocytes from the HepaRG cell line became able to
accumulate iron (Figs. 1B and 1C), suggesting that these
processes are involved, or at least are markers of their
involvement, in this function.
Finally, under basal culture conditions, from supercon-
fluence to differentiation, during the final differentiation step,genes involved in lipid and fatty acid metabolism were
overexpressed and genes involved in biosynthesis, energy
pathways, and macromolecule metabolism were down-regu-
lated (Table 3). In addition, in terms of enriched GO
molecular functions (data not shown), the overexpression of
genes involved in oxidoreductase activity, with a high
representation of cytochrome p450 family members (e.g.,
CYP3A4, CYP4F2, CYP2E1, and CYP2A6), was significant at
this final stage of differentiation (see also Table 4). In
parallel, iron loading capacity was maintained during this
phase.
Iron metabolism, gene expression, and differentiation status
We focused our analysis on the relationship between iron
storage capacity and the expression of genes that were linked
to iron metabolism either directly or through their involvement
in hematopoiesis or the requirement of iron binding with their
protein products for full activity (Table 4). In particular, we
identified that the NFE2L2 gene, involved in hematopoeisis, is
Fig. 2. Validation of hybridization results by quantitative RT-PCR. Values, obtained using microarrays (A) or quantitative RT-PCR (B), of log 2 of the ratio of mRNA
levels at the differentiation stage compared to the proliferation stage. na, not available. Significantly modulated genes (*) were selected by Significance Analysis of
Microarray and limma for microarray results and by the Mann-Whitney test with P < 0.05 for quantitative RT-PCR results.
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some genes encoding cytochromes c or other iron-binding
proteins (CYCS, COX7B, COX4I1, and MT1G). In contrast,
the expression of genes encoding cytochrome p450 (CYP3A4,
CYP2A6, CYP2E1, and CYP4F2) and plasmatic iron trans-
porters (HPX, HP, and TF) were up-regulated. Furthermore,
the ferritin H gene, involved in iron storage, was down-
regulated when HepaRG cells reached superconfluence.
Finally, when cells reached differentiation, we noted CAT
overexpression and CP underexpression. For the other genes,
no precise pattern was found. The expression patterns of
NFE2L2, HP, TF, and CP were validated by quantitative PCR
(Fig. 2).
Discussion
To examine whether there was a relationship between
hepatocyte status and iron storage capacity, we analyzed
biological processes modulated along HepaRG differentiation
in relation to the iron loading capacity of hepatocytes. For this
purpose, we used a custom liver microarray and an application
combining a statistical tool and gene annotations.In contrast to other human hepatocyte-derived cell lines,
HepaRG cells evolved from an undifferentiated bipotent state
to a hepatocyte differentiated state, expressing a very high level
of hepatocyte-specific genes and functions similar to those of
primary cultures of hepatocytes [13,15]. In this study, we were
able to demonstrate that, like human hepatocytes, the HepaRG
cell line also supports iron overload. The coherence of the
model of HepaRG differentiation with paired hepatocellular
carcinoma human samples, based on eight expression pattern
profiles (RAC1, MSN, TPM3, FN1 , FABP1, CYP4F2,
UGT2B7, and PLCG2), illustrated the relevance of this cell
line.
Among these eight genes, we identified three genes that
were clearly up-regulated in liver tumor versus nontumoral
livers. RAC1 (ras-related C3 botulinum toxin substrate 1),
encoding a small GTP-binding protein, is involved in cell
motility, cell adhesion, and cytoskeletal reorganization. MSN
(moesin) is localized in filopodia and membranous protrusions.
TPM3 encodes tropomyosin 3, a protein of the cytoskeleton.
All three genes play a role in carcinogenesis [19–21], but none
of them have yet been found to be overexpressed in
hepatocellular carcinoma. These results lead us to propose
Table 3
Statistical enrichment in some GO biological processes and global modulation of corresponding genes, along HepaRG differentiation
Terms in majuscules and in bold characters are respectively GO terms from levels 4 and 5, others are from lower layers. A color code is given for the statistical p-
value of enrichment calculation ( p < 0.01 in sweet colour, p < 0.001 in hard color, blue for non significant enrichment). An arrow code is attributed to gene
modulation (overexpression in green, with up-arrow; underexpression in red with down-arrow). A gene can be annotated by several terms.
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with hepatocellular carcinoma.
The HepaRG cell line has a bipotent evolution through
hepatocyte-like and biliary-like cells. This dual evolution,
which may play a role in the appearance of hepatocyte
differentiation due to interactions between both cell types
[22], may cause heterogeneity in mRNAs and may lead to a
misinterpretation of gene expression profiles. However, con-
tamination by primitive biliary cells does not exceed 40% of
the cells at the differentiated state of the culture, based on both
immunolocalizations from Parent et al. [14] and phase-contrast
microscopy showing large hepatocyte colonies (Fig. 1).Moreover, biliary cell mRNA content is much lower than
hepatocyte mRNA content. This is correlated with the weak
representativity of biliary-specific genes of our panel of genes
selected from suppressive subtractive hybridization libraries
from HepaRG differentiation. Thus, our dedicated microarray
is an advantage in lessening the impact of the presence of
biliary-like cells in the culture. Moreover, under these culture
conditions, biliary cells likely correspond to primitive ductular
cells [14]. Indeed, of 15 genes previously presented as specific
biliary markers [14,23], only 4 are represented in our
microarray: ITGB4 (integrin h4), ITGA5 (integrin a5), MME
(or CD10, also named membrane metallo-endopeptidase), and
Fig. 3. Gene expression profiles in human hepatocellular carcinoma. Gene expression profiles were studied in 12 cases of human hepatocellular carcinoma. Results
are expressed as log 2 of the ratio of mRNA levels in a nontumoral liver area compared to a tumoral area of liver for (A) genes implicated in cell motility and (B)
genes implicated in lipid metabolism. mRNA levels of genes implicated in cell motility were down-regulated, whereas those of genes involved in lipid metabolism
were globally up-regulated. Significance was attributed for *P < 0.05 and **P < 0.01 by a paired T test.
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(ITGA5 and CD59), or invariant (ITGB4 and MME) along
HepaRG differentiation kinetics (see gene expression in the
Supplementary data found in the online version of this article).
Thus, this cDNA microarray reflected more the hepatocyte
lineage than the biliary lineage, allowing us to focus our studyTable 4
Modulation of RNA level of iron metabolism genes along HepaRG differentiation
Differentially expressed genes are selected both by Significance Analysis of Microa
base 2 of the ratio indicated in the table.on the hepatocyte differentiation of the HepaRG cell line in
relation to iron storage capacity.
To overcome the truncated view of the whole transcrip-
tome given by our custom microarray, we studied the modu-
lation of biological processes using the GoMiner application
to characterize the HepaRG differentiation kinetics. The useprocess
rray analysis and limma analysis. Expression levels are expressed in logarithme
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identification of more networks. However, we identified a
cluster of genes with a down-regulated expression profile.
The association of these genes in a common regulatory
network needs further investigation as for the three un-
annotated genes from the GO biological process (GenBank
Accession Nos. AK055641, AX198942, and NM_004467).
The roles of these genes in HepaRG differentiation kinetics
remain to be defined.
We demonstrate that modulation of cell motility, response to
stimulus, and immune response gene expression (at the
confluence and superconfluence stages) clearly preceded the
expression of massive hepatocyte functions (at the differenti-
ation stage). Modulated genes at these stages of differentiation
are potential candidates for the appearance of the hepatocyte
phenotype, as occurring in coculture by interactions between
hepatocytes and biliary cells [22].
Both HepaRG differentiation and liver regeneration require
the orchestration of pathways controlling cell differentiation
and proliferation. We found, comparing two different studies
[24,25] that examined mice regenerating livers, a similar
expression profile for genes implicated in the acute-phase
response and inflammatory response, among them ORM1 (a-1
acid glycoprotein 1B), ORM2, FGA, and FGB, which are
overexpressed in mice regenerating livers and in HepaRG cells,
at least until superconfluence. In the same way, the expression
of hepatic lipid accumulation is specifically regulated during
liver regeneration [26], which parallels the overexpression of
lipid metabolism genes along HepaRG differentiation. This
suggests that the HepaRG cell line could be a valuable model
for studying the hepatocyte regeneration process. An alteration
of normal expression of these genes could play a role in the
development of liver diseases, especially during hepatic
regeneration and oxidative stress.
In this work, we found that HepaRG cells cannot undergo
iron loading when genes involved in cell proliferation are
highly expressed. In contrast, HepaRG iron load capacity
occurs with the appearance of hepatocyte-like cells and is
maintained at the highest differentiated stage. This iron storage
capacity can be first associated with the down-regulation of
genes implicated in cell motility and in the protein kinase
cascade. This sharp dichotomy—non-iron load capacity linked
to high cell growth and/or maintenance activity as opposed to
iron load capacity related to a decrease in motility and
migration capacity—is in accordance with clinical observa-
tions in hepatocellular carcinoma. Indeed, proliferative, i.e.,
potentially more motile, hepatocellular carcinoma cells are
always iron-poor, even if the corresponding nontumoral liver is
iron-overloaded [12]. This is also consistent with the descrip-
tion of the iron-poor phenotype of iron-free foci, which are
proliferative and potential preneoplastic lesions, in the non-
tumoral liver of untreated genetic hemochromatosis patients
[27,28]. Iron overload capacity is also associated with the up-
regulation of genes involved in the response to stress and the
immune response, suggesting that some of these genes are
required to protect hepatocytes against pathogens and exoge-
nous agents, including iron excess. Finally, the absence ofstainable iron in biliary-like cells fits well with the delay of the
iron overload of biliary cells compared to hepatocytes in
human liver iron overload especially during genetic hemo-
chromatosis [28].
Our data demonstrate that the iron storage behavior of
HepaRG cells depends on the hepatocyte differentiation status.
These data are consistent with a previous report showing that
differentiation in CaCo-2 cells, a model of enterocytes and
implicated in iron absorption, is associated with a decrease in
the expression of genes involved in the cell cycle and with
signal transduction, whereas an increase in the expression of
genes linked to lipid metabolism and the immune response, as
well as the modulation of genes involved in iron metabolism,
was reported [29].
Concerning gene modulation in iron metabolism, during the
evolution from HepaRG confluence to superconfluence in the
absence of iron supplementation, an increased expression was
found for hemopexin, haptoglobin, and transferrin genes,
which encode iron plasmatic transporters, suggesting their
association with iron storage capacity. Conversely, the expres-
sion of ferritin H (FTH1) and NFE2L2 (also named NRF2)
mRNAs decreased. The NFE2L2 transcription factor is known
to regulate the expression of some iron metabolism genes, such
as HMOX1, TXNL, SOD1, and CAT [30], and could also
mediate the transcriptional induction of FTH1 and FTL
mRNAs [31]. Although FTH1 mRNA is also known to be
translationally regulated through iron regulatory proteins,
encoded by ACO1 and IREB2 genes [7], the similarity in
expression patterns between the NFE2L2 and FTH1 genes in
HepaRG cells evokes, in humans, the possible transcriptional
control of the FTH1 gene by the NFE2L2 transcription factor,
suggesting the involvement of NFE2L2 in iron storage capacity
in the liver. This hypothesis is reinforced by a recent report
demonstrating that Nrf2/ mice had an increase in liver iron
content [32].
In conclusion, our study demonstrates that hepatocyte iron
loading capacity is strongly associated with both the decrease
in cell motility and the appearance of highly differentiated
hepatocyte functions including xenobiotic metabolism, lipid
metabolism, or response to stress. We also highlight new genes
associated with the hepatocyte differentiation process and
propose new genes potentially related to hepatocellular
carcinoma. Taken together, these data suggest that identified
biological processes and related genes represent good candi-
dates for the understanding of: (i) the relationship between iron
metabolism and hepatocyte differentiated status and (ii) the
switch between hepatocyte differentiation and proliferation,
especially during liver regeneration. They could lead to the
identification of new diagnostic or therapeutic targets useful for
the follow-up of patients with chronic liver diseases.
Materials and methods
HepaRG cell culture, iron exposure, and Perls_ staining
The HepaRG cell line was cultured in basal medium as previously
described [13]. We considered four distinct stages of the differentiation process:
proliferating cells (day 3 postspreading), confluent cells (days 5 and 6),
M.-B. Troadec et al. / Genomics 87 (2006) 93–103 101superconfluent cells (days 12–15), and finally differentiated cells (day 30 with
the last 15 days in basal medium supplemented with 2% dimethylsulfoxide).
When applicable, exposure to iron excess was performed using 20 AM iron–
citrate (1 iron/10 citrate) [33] or 200 AM citrate as control for 48 h with a daily
renewed culture medium at the four distinct stages of differentiation. Perls_
staining revealed an excess of intracellular iron [34].
Construction of the human liver dedicated cDNA microarray
We performed four suppressive subtractive hybridization libraries [35] with
the PCR Select cDNA Subtraction Kit (Clontech, Palo Alto, CA) on human
hepatocarcinoma samples versus nontumoral human livers, obtained in
accordance with French laws and regulations, and on HepaRG cells at
proliferation versus differentiation stages. Clones were sequenced at Genoscope
(Evry, France) and massive BLASTs were performed with PCIO informatics
facilities (Rennes, France). A total of 2436 PCR-amplified cDNA clones,
supplemented with 36 PCR-amplified iron metabolism cDNAs and several
controls [human h-actin cDNA, cDNAs corresponding to Cab, RCA, or rbcl
genes from Arabidopsis thaliana (Spot Report Array Validation System,
Stratagene)], corresponding to 584 human distinct genes (the list of genes is
available at http://u522.rennes.inserm.fr/donnees/troadec.htm), were spotted in
duplicate onto precoated glass slides (CMT-GAPS, Corning).
Poly(A) RNA isolation and fluorescence labeling
Total RNAs were isolated by ultracentrifugation under denaturing conditions
[36]. RNA quality was assayed by electrophoresis migration on agarose gel. The
absence of genomic DNAwas verified by PCR using human h-actin primers and
by using a lab chip device (Agilent 2100 Bioanalyzer). Poly(A) RNAs were
extracted with a large-scale mRNA isolation kit (Miltenyi Biotec). The quality
and quantity of purified poly(A) were assayed on the Agilent 2100 Bioanalyzer.
Poly(A)s were then labeled using a CyScribe Postlabeling Kit (Amersham)
according to the manufacturer_s instructions. Each sample was labeled with Cy3
dye and then with Cy5 dye, for further dye-swap hybridizations.
Experimental design, hybridization, and scanning
We compared the four stages of differentiation in a loop design (Fig. 4) and
performed two independent experiments. Each hybridization was performed in
dye-swap. We followed the hybridization protocol available on the Web (http://
cardioserve.nantes.inserm.fr/ptf-puce/) (protocols 7 and 9). Fluorescence was
read on a ScanArray Express 4000 XL (Packard Bioscience). Image analyses
were performed with Genepix Pro 4.0 (Axon, Union City, USA).
Data processing
Raw data, expressed as log 2 of the expression ratio, were preprocessed
through the MADSCAN application available on the Web [29,37] by theFig. 4. Experimental design of hybridizations performed in this study. n denotes
the number of different hybridizations; double arrows represent dye-swap
hybridizations.lowess fitness normalization and a scaling on the internal variance of each
replicated array. To remove nonreproducible values, data were then
processed on replicated spots in a single array, on replicated arrays, and
finally on redundant genes. Heterogeneous spots, signals below the detection
level, and insufficiently reproducible values were identified as not available
(na).
Identification of differentially expressed genes
We combined two methods to point out differentially expressed genes. In
the Significance Analysis of Microarray method (SAM) [38], the cut-off for
significance was determined by the minimal false discovery rate calculated
between our data and a randomized matrix of these data. In the limma method,
available in the R-package [39], which lies on an empirical Bayes moderated T
test, the cut-off for significance is a P value of less than 0.05. Significantly
differentially expressed genes were the common list of differentially expressed
genes selected by both SAM analysis and limma analysis.
Statistical enrichment of biological processes
The Gene Ontology Consortium [40] annotates the genome through
categories of biological processes. Annotations are organized in a tree-like
structure with several levels. The calculation of statistical enrichment of GO
annotations of significantly modulated genes compared to total array genes at
every level of the GO hierarchy was delivered through the GoMiner application
available on the Web [41]. The statistical calculation consisted of a two-sided P
value from Fisher_s exact test between the total set of the gene array and the
subset of significantly modulated genes. A P value of less than 0.01 was
considered statistically significant.
Quantitative real-time RT-PCR validation
Twenty genes were selected for validation using quantitative real-time PCR.
Primer design was performed with the assistance of Primer Express software
(PE Biosystems). These genes were as follows: ADH1B, AFP, CP, CYBRD1,
CYP4F2, DDEF1, FABP1, FN1, HP, MSN, NFE2L2, PLCG2, RAC1, RNF10,
SELENBP1, SLC11A2, TF, TFRC, TPM3, and UGT2B7. Primers are available
at http://u522.rennes.inserm.fr/donnees/troadec.html. All quantitative real-time
PCR assays were performed using qPCR core reagent kit for SybrGreen1
(Eurogentec, Belgium) on an ABI Prism 7000 SDS (Applied Bioscience,
London, UK): 95-C for 10 min followed by 40 cycles of 95-C for 15 s and
60-C for 1 min. Expression data were normalized using 18S rRNA endogenous
reference.
Human liver samples
Paired nontumoral and tumoral liver samples of 12 patients operated on for
hepatocellular carcinoma were obtained from the Biological Resource Center of
Rennes after local ethical committee approval and after obtaining informed
consent from patients. Total RNA extraction and reverse transcription were
performed as previously described [42].
Statistical analysis
For quantitative PCR results, the Mann-Whitney test or paired T test were
performed by StatView software. Significance was attributed for P < 0.05.
Acknowledgments
We thank OUEST Genopole and IFR 140 for transcriptome
core facilities, the Biological Resource Center for supplying
human samples, and Dr. B. Turlin (pathologist). This work was
supported by a PRIR (No. 139) of the Re´gion Bretagne, the
French Ministry of Research and Technology (M.B.T. and
M.-B. Troadec et al. / Genomics 87 (2006) 93–103102E.G.), the Association Fer et Foie, and the European
Community QLRT-2001-00444 contract.
Appendix A. Supplementary data
Supplementary data associated with this article can be found
in the online version at doi:10.1016/j.ygeno.2005.08.016.
References
[1] P. Aisen, A. Leibman, R.A. Pinkowitz, The anion-binding functions of
transferrin, Adv. Exp. Med. Biol. 48 (1974) 125–140.
[2] A. vander Straten, A. Herzog, P. Jacobs, T. Cabezon, A. Bollen, Molecular
cloning of human haptoglobin cDNA: Evidence for a single mRNA
coding for alpha 2 and beta chains, EMBO J. 2 (1983) 1003–1007.
[3] S.L. Naylor, F. Altruda, A. Marshall, L. Silengo, B.H. Bowman,
Hemopexin is localized to human chromosome 11, Somat. Cell. Mol.
Genet. 13 (1987) 355–358.
[4] C. Pigeon, G. Ilyin, B. Courselaud, P. Leroyer, B. Turlin, P. Brissot, O.
Lore´al, A new mouse liver-specific gene, encoding a protein homologous
to human antimicrobial peptide hepcidin, is overexpressed during iron
overload, J. Biol. Chem. 276 (2001) 7811–7819.
[5] C.M. Craven, J. Alexander, M. Eldridge, J.P. Kushner, S. Bernstein, J.
Kaplan, Tissue distribution and clearance kinetics of non-transferrin-
bound iron in the hypotransferrinemic mouse: A rodent model for
hemochromatosis, Proc. Natl. Acad. Sci. USA 84 (1987) 3457–3461.
[6] P. Brissot, T.L. Wright, W.L. Ma, R.A. Weisiger, Efficient clearance of
non-transferrin-bound iron by rat liver. Implications for hepatic iron
loading in iron overload states, J. Clin. Invest. 76 (1985) 1463–1470.
[7] E.C. Theil, Ferritin: Structure, gene regulation, and cellular function in
animals, plants, and microorganisms, Annu. Rev. Biochem. 56 (1987)
289–315.
[8] J.N. Feder, A. Gnirke, W. Thomas, Z. Tsuchihashi, D.A. Ruddy, A.
Basava, F. Dormishian, R. Domingo Jr., M.C. Ellis, A. Fullan, L.M.
Hinton, N.L. Jones, B.E. Kimmel, G.S. Kronmal, P. Lauer, V.K. Lee, D.B.
Loeb, F.A. Mapa, E. McClelland, N.C. Meyer, G.A. Mintier, N. Moeller,
T. Moore, E. Morikang, R.R. Wolff, et al., A novel MHC class I-like gene
is mutated in patients with hereditary haemochromatosis, Nat. Genet. 13
(1996) 399–408.
[9] P. Brissot, Y. Deugnier, Haemochromatosis, in: J. Bircher, J.P. Benhamou,
N. Mcintyre, M. Rizetto, J. Rodes (Eds.), Oxford Textbook of Clinical
Hepatology, Oxford University Press, 1999, pp. 1379–1391.
[10] C. Niederau, R. Fischer, A. Sonnenberg, W. Stremmel, H.J. Trampisch, G.
Strohmeyer, Survival and causes of death in cirrhotic and in noncirrhotic
patients with primary hemochromatosis, N. Engl. J. Med. 313 (1985)
1256–1262.
[11] Y. Deugnier, B. Turlin, D. le Quilleuc, R. Moirand, O. Loreal, M.
Messner, B. Meunier, P. Brissot, B. Launois, A reappraisal of hepatic
siderosis in patients with end-stage cirrhosis: Practical implications for the
diagnosis of hemochromatosis, Am. J. Surg. Pathol. 21 (1997) 669–675.
[12] B. Turlin, F. Juguet, R. Moirand, D. Le Quilleuc, O. Loreal, J.P. Campion,
B. Launois, M.P. Ramee, P. Brissot, Y. Deugnier, Increased liver iron
stores in patients with hepatocellular carcinoma developed on a noncir-
rhotic liver, Hepatology 22 (1995) 446–450.
[13] P. Gripon, S. Rumin, S. Urban, J. Le Seyec, D. Glaise, I. Cannie, C.
Guyomard, J. Lucas, C. Trepo, C. Guguen-Guillouzo, Infection of a
human hepatoma cell line by hepatitis B virus, Proc. Natl. Acad. Sci. USA
99 (2002) 15655–15660.
[14] R. Parent, M.J. Marion, L. Furio, C. Trepo, M.A. Petit, Origin and
characterization of a human bipotent liver progenitor cell line, Gastroen-
terology 126 (2004) 1147–1156.
[15] P. Gripon, I. Cannie, S. Urban, Efficient inhibition of hepatitis B virus
infection by acylated peptides derived from the large viral surface protein,
J. Virol. 79 (2005) 1613–1622.
[16] M. Grootveld, J.D. Bell, B. Halliwell, O.I. Aruoma, A. Bomford, P.J.
Sadler, Non-transferrin-bound iron in plasma or serum from patients withidiopathic hemochromatosis. Characterization by high performance liquid
chromatography and nuclear magnetic resonance spectroscopy, J. Biol.
Chem. 264 (1989) 4417–4422.
[17] R.C. Hider, Nature of nontransferrin-bound iron, Eur. J. Clin. Invest. 32
(Suppl. 1) (2002) 50–54.
[18] Y.M. Deugnier, B. Turlin, L.W. Powell, K.M. Summers, R. Moirand, L.
Fletcher, O. Lore´al, P. Brissot, J.W. Halliday, Differentiation between
heterozygotes and homozygotes in genetic hemochromatosis by means of
a histological hepatic iron index: A study of 192 cases, Hepatology 17
(1993) 30–34.
[19] S. Aznar, J.C. Lacal, Rho signals to cell growth and apoptosis, Cancer
Lett. 165 (2001) 1–10.
[20] H. Kobayashi, J. Sagara, H. Kurita, M. Morifuji, M. Ohishi, K. Kurashina,
S. Taniguchi, Clinical significance of cellular distribution of moesin in
patients with oral squamous cell carcinoma, Clin. Cancer Res. 10 (2004)
572–580.
[21] L. Lamant, N. Dastugue, K. Pulford, G. Delsol, B. Mariame, A new fusion
gene TPM3-ALK in anaplastic large cell lymphoma created by a (1;2)
(q25;p23) translocation, Blood 93 (1999) 3088–3095.
[22] J.M. Fraslin, B. Kneip, S. Vaulont, D. Glaise, A. Munnich, C.
Guguen-Guillouzo, Dependence of hepatocyte-specific gene expression
on cell –cell interactions in primary culture, EMBO J. 4 (1985)
2487–2491.
[23] J.Y. Scoazec, A.F. Bringuier, J.F. Medina, E. Martinez-Anso, D. Veissiere,
G. Feldmann, C. Housset, The plasma membrane polarity of human
biliary epithelial cells: in situ immunohistochemical analysis and
functional implications, J. Hepatol. 26 (1997) 543–553.
[24] N. Kelley-Loughnane, G.E. Sabla, C. Ley-Ebert, B.J. Aronow, J.A.
Bezerra, Independent and overlapping transcriptional activation during
liver development and regeneration in mice, Hepatology 35 (2002)
525–534.
[25] M. Arai, O. Yokosuka, T. Chiba, F. Imazeki, M. Kato, J. Hashida, Y. Ueda,
S. Sugano, K. Hashimoto, H. Saisho, M. Takiguchi, N. Seki, Gene
expression profiling reveals the mechanism and pathophysiology of
mouse liver regeneration, J. Biol. Chem. 278 (2003) 29813–29818.
[26] E. Shteyer, Y. Liao, L.J. Muglia, P.W. Hruz, D.A. Rudnick, Disruption of
hepatic adipogenesis is associated with impaired liver regeneration in
mice, Hepatology 40 (2004) 1322–1332.
[27] Y.M. Deugnier, P. Charalambous, D. Le Quilleuc, B. Turlin, J. Searle, P.
Brissot, L.W. Powell, J.W. Halliday, Preneoplastic significance of hepatic
iron-free foci in genetic hemochromatosis: a study of 185 patients,
Hepatology 18 (1993) 1363–1369.
[28] Y.M. Deugnier, O. Lore´al, B. Turlin, D. Guyader, H. Jouanolle, R.
Moirand, C. Jacquelinet, P. Brissot, Liver pathology in genetic hemochro-
matosis: A review of 135 homozygous cases and their bioclinical
correlations, Gastroenterology 102 (1992) 2050–2059.
[29] H. Bedrine-Ferran, N. Le Meur, I. Gicquel, M. Le Cunff, N. Soriano, I.
Guisle, S. Mottier, A. Monnier, R. Teusan, P. Fergelot, J.Y. Le Gall, J.
Leger, J. Mosser, Transcriptome variations in human CaCo-2 cells: A
model for enterocyte differentiation and its link to iron absorption,
Genomics 83 (2004) 772–789.
[30] K. Chan, X.D. Han, Y.W. Kan, An important function of Nrf2 in
combating oxidative stress: Detoxification of acetaminophen, Proc. Natl.
Acad. Sci. USA 98 (2001) 4611–4616.
[31] E.C. Pietsch, J.Y. Chan, F.M. Torti, S.V. Torti, Nrf2 mediates the induction
of ferritin H in response to xenobiotics and cancer chemopreventive
dithiolethiones, J. Biol. Chem. 278 (2003) 2361–2369.
[32] T. Yanagawa, K. Itoh, J. Uwayama, Y. Shibata, A. Yamaguchi, T. Sano, T.
Ishii, H. Yoshida, M. Yamamoto, Nrf2 deficiency causes tooth decolour-
ization due to iron transport disorder in enamel organ, Genes Cells 9
(2004) 641–651.
[33] P. Azari, R.F. Baugh, A simple and rapid procedure for preparation of
large quantities of pure ovotransferrin, Arch. Biochem. Biophys. 118
(1967) 128–144.
[34] R. Hould, Techniques d_histopathologie et de cytopathologie, De´carie,
Montre´al.
[35] L. Diatchenko, Y.F. Lau, A.P. Campbell, A. Chenchik, F. Moqadam, B.
Huang, S. Lukyanov, K. Lukyanov, N. Gurskaya, E.D. Sverdlov, P.D.
M.-B. Troadec et al. / Genomics 87 (2006) 93–103 103Siebert, Suppression subtractive hybridization: A method for generating
differentially regulated or tissue-specific cDNA probes and libraries, Proc.
Natl. Acad. Sci. USA 93 (1996) 6025–6030.
[36] J.M. Chirgwin, A.E. Przybyla, R.J. MacDonald, W.J. Rutter, Isolation of
biologically active ribonucleic acid from sources enriched in ribonuclease,
Biochemistry 18 (1979) 5294–5299.
[37] N. Le Meur, G. Lamirault, A. Bihouee, M. Steenman, H. Bedrine-
Ferran, R. Teusan, G. Ramstein, J.J. Leger, A dynamic, web-accessible
resource to process raw microarray scan data into consolidated gene
expression values: Importance of replication, Nucleic Acids Res. 32
(2004) 5349–5358.
[38] V.G. Tusher, R. Tibshirani, G. Chu, Significance analysis of microarrays
applied to the ionizing radiation response, Proc. Natl. Acad. Sci. USA 98
(2001) 5116–5121.
[39] R. Ihaka, R. Gentleman, R: A language for data analysis and graphics,
J. Comput. Graph. Stat. 5 (1996) 299–314.[40] M. Ashburner, C.A. Ball, J.A. Blake, D. Botstein, H. Butler, J.M. Cherry,
A.P. Davis, K. Dolinski, S.S. Dwight, J.T. Eppig, M.A. Harris, D.P. Hill,
L. Issel-Tarver, A. Kasarskis, S. Lewis, J.C. Matese, J.E. Richardson, M.
Ringwald, G.M. Rubin, G. Sherlock, Gene ontology: Tool for the
unification of biology. The Gene Ontology Consortium, Nat. Genet. 25
(2000) 25–29.
[41] B.R. Zeeberg, W. Feng, G. Wang, M.D. Wang, A.T. Fojo, M. Sunshine, S.
Narasimhan, D.W. Kane, W.C. Reinhold, S. Lababidi, K.J. Bussey, J. Riss,
J.C. Barrett, J.N. Weinstein, GoMiner: A resource for biological
interpretation of genomic and proteomic data, Genome Biol. 4 (2003)
R28.
[42] L. Detivaud, E. Nemeth, K. Boudjema, B. Turlin, M.B. Troadec, P.
Leroyer, M. Ropert, S. Jacquelinet, B. Courselaud, T. Ganz, P. Brissot,
O. Lore´al, Hepcidin levels in humans are correlated with hepatic iron
stores, hemoglobin levels and hepatic function, Blood 106 (2005)
746–748.
